ABOUT US

First Analysis has a four-decade record of serving emerging growth companies, established industry leaders, and institutional investors in emerging high-growth segments in technology and healthcare, both through its venture capital investments and through First Analysis Securities Corp. (FASC), which provides investment banking and related services. FASC is a FINRA-registered broker-dealer and member SIPC. First Analysis’s integrative research process underpins all its efforts, combining 1) dynamic investment research on thousands of companies with 2) thousands of relationships among executives, investors, and other key participants in our focus areas, yielding a deep, comprehensive understanding of each sector’s near-term and long-term potential.

FIRST ANALYSIS NEWS
First Analysis invests in Lender Price, a leader in lending technology
First Analysis, a leading venture capital investor, has made a new investment in Lender Price. Lender Price’s cloud-based solutions help banks, mortgage bankers and mortgage brokers increase volumes and profitability, benefit from workflow efficiencies and improve their market competitiveness. The investment, led by longtime First Analysis partner Argentum Group, will further accelerate Lender Price’s rapid growth by supporting product development, sales and marketing and customer service capabi
October 15, 2021
First Analysis, a leading venture capital investor, has made a new investment in Lender Price. Lender Price’s cloud-based solutions help banks, mortgage bankers and mortgage brokers increase volumes and profitability, benefit from workflow efficiencies and improve their market competitiveness. The investment, led by longtime First Analysis partner Argentum Group, will further accelerate Lender Price’s rapid growth by supporting product development, sales and marketing and customer service capabi
October 15, 2021
First Analysis acted as the exclusive financial advisor to Selerix Systems for its investment by NexPhase Capital
First Analysis acted as the exclusive financial advisor to Selerix in securing an investment from NexPhase Capital. Selerix produces software used by employers, brokers and carriers to simplify benefits administration, employee engagement and Affordable Care Act (ACA) reporting. The terms of the transaction were not disclosed.
August 26, 2021
First Analysis acted as the exclusive financial advisor to Selerix in securing an investment from NexPhase Capital. Selerix produces software used by employers, brokers and carriers to simplify benefits administration, employee engagement and Affordable Care Act (ACA) reporting. The terms of the transaction were not disclosed.
August 26, 2021
First Analysis acted as the exclusive financial advisor to Healthify in its sale to WellSky®
First Analysis acted as the exclusive financial advisor to Healthify in its sale to WellSky, a leading health and community care technology company. Healthify improves the health of communities by connecting healthcare organizations with social service organizations to address the social determinants of health (SDoH). Healthify's past investors include SV Health Investors, Sandbox Ventures, Activate Venture Partners, Primary Venture Partners and Acumen. The terms of the transaction were not disc
August 03, 2021
First Analysis acted as the exclusive financial advisor to Healthify in its sale to WellSky, a leading health and community care technology company. Healthify improves the health of communities by connecting healthcare organizations with social service organizations to address the social determinants of health (SDoH). Healthify's past investors include SV Health Investors, Sandbox Ventures, Activate Venture Partners, Primary Venture Partners and Acumen. The terms of the transaction were not disc
August 03, 2021

CONTACT INFORMATION

One South Wacker Drive
Suite 3900
Chicago, Illinois 60606
312-258-1400

©2021 by First Analysis Corporation.
One South Wacker Drive
  ·  
Suite 3900
  ·  
Chicago, IL 60606
  ·  
312-258-1400